- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00609427
Effects of Cognitive Intervention for Older Adults With Memory Decline: A Pilot Study
June 1, 2010 updated by: McGill University Health Centre/Research Institute of the McGill University Health Centre
The purpose of this study is to evaluate the effects of training in memory skills vs. use of external memory aids on everyday memory functioning in older people with mild cognitive impairment.
Study Overview
Status
Completed
Conditions
Detailed Description
Some older people experience memory loss that is worse than other people of their age, although they are not demented.
This condition is known as mild cognitive impairment (MCI).
Healthy older people can learn mnemonic strategies to improve their memory abilities.
Can cognitive rehabilitation help people with MCI do better on mental tasks or maintain better functioning in everyday life?
This study will evaluate the effects of two different rehabilitation programmes.
Patients in the memory training group will learn mental strategies aimed at improving memory.
Patients in the memory compensation group will learn to use external memory aids.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3A 1A1
- McGill University Health Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 90 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of mild cognitive impairment
Exclusion Criteria:
- Unable to speak and understand English
- Unable to comply with treatment program due to significant comorbid illness; OR
- Anticipated inability to attend all study sessions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EA
Training in external memory aids
|
8 weekly group sessions of training in the use of external memory aids, administered by clinical psychologist
|
Experimental: MT
Mnemonic training intervention
|
8 weekly group training sessions in mnemonic strategies, administered by clinical psychologist.
|
No Intervention: WL
Wait-list control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rey Auditory Verbal Learning Test
Time Frame: 19-20 weeks
|
19-20 weeks
|
Wechsler Memory Scale - Logical Memory
Time Frame: 19-20 weeks
|
19-20 weeks
|
Face-name associations test
Time Frame: 19-20 weeks
|
19-20 weeks
|
Multifactorial Memory Questionnaire - Ability subscale
Time Frame: 19-20 weeks
|
19-20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rivermead Behavioural Memory Test
Time Frame: 19-20 weeks
|
19-20 weeks
|
FAS test (non-memory)
Time Frame: 19-20 weeks
|
19-20 weeks
|
Category fluency (non-memory test)
Time Frame: 19-20 weeks
|
19-20 weeks
|
Victoria Stroop Test (non-memory test)
Time Frame: 19-20 weeks
|
19-20 weeks
|
Digit Span (non-memory test)
Time Frame: 19-20 weeks
|
19-20 weeks
|
Multifactorial Memory Questionnaire - Strategies and Contentment subscales
Time Frame: 19-20 weeks
|
19-20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lisa Koski, PhD, Research Institute of the McGill University Health Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
January 24, 2008
First Submitted That Met QC Criteria
February 6, 2008
First Posted (Estimate)
February 7, 2008
Study Record Updates
Last Update Posted (Estimate)
June 2, 2010
Last Update Submitted That Met QC Criteria
June 1, 2010
Last Verified
June 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSY-07-015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on External memory aids training
-
National Institute of Nursing Research (NINR)CompletedHIV | Mental IllnessUnited States
-
Johns Hopkins UniversityTerminatedSubstance-Related DisordersUnited States
-
Icahn School of Medicine at Mount SinaiCompletedDepression | Generalized Anxiety Disorder | Bipolar Disorder | Major Depressive Disorder | Social Phobia | Post-traumatic Stress DisorderUnited States
-
Henry Ford Health SystemNot yet recruiting
-
University of GeorgiaRecruitingSchizophrenia | Schizo Affective DisorderUnited States
-
Milwaukee VA Medical CenterCompletedPosttraumatic Stress DisorderUnited States
-
VA Office of Research and DevelopmentUniversity of MarylandCompleted
-
University of CalgaryBrain & Behavior Research FoundationTerminatedPsychotic Disorders
-
Radboud University Medical CenterNetherlands Organisation for Scientific ResearchCompletedAttention Deficit Disorder With HyperactivityNetherlands